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The cyclophilin SnuCyp-20 is a specific component of
the human U4/U6 small nuclear ribonucleoprotein par-
ticle involved in the nuclear splicing of pre-mRNA. It
stably associates with the U4/U6-60kD and -90kD pro-
teins, the human orthologues of the Saccharomyces cer-
evisiae Prp4 and Prp3 splicing factors. We have deter-
mined the crystal structure of SnuCyp-20 at 2.0-Å
resolution by molecular replacement. The structure of
SnuCyp-20 closely resembles that of human cyclophilin
A (hCypA). In particular, the catalytic centers of
SnuCyp-20 and hCypA superimpose perfectly, which is
reflected by the observed peptidyl-prolyl-cis/trans-
isomerase activity of SnuCyp-20. The surface properties
of both proteins, however, differ significantly. Apart
from seven additional amino-terminal residues, the in-
sertion of five amino acids in the loop a1-b3 and of one
amino acid in the loop a2-b8 changes the conformations
of both loops. The enlarged loop a1-b3 is involved in the
formation of a wide cleft with predominantly hydropho-
bic character. We propose that this enlarged loop
is required for the interaction with the U4/U6-60kD
protein.
The nuclear splicing of pre-mRNA is catalyzed by the spli-
ceosome, which is a highly dynamic macromolecular assembly
formed by the ordered interaction of the snRNPs1 U1, U2,
U4/U6, and U5 and of several non-snRNP proteins (for review
see Refs. 1–3). Although the U1 and U2 snRNPs bind to the
59-splice site and the branch point of the pre-mRNA, respec-
tively, the U4/U6 and U5 snRNPs pre-assemble to the [U4/
U6.U5] tri-snRNP. After association of the tri-snRNP with the
pre-spliceosome, the mature and active spliceosome is formed
in a process that involves extreme rearrangements of the spli-
ceosomal RNA components. Thus, before the first catalytic step
of the transesterification reaction, the U4/U6 snRNA duplex is
disrupted, resulting in the release of U4 snRNA and the asso-
ciation of U6 snRNA with U2 snRNA and the pre-mRNA (re-
viewed in Ref. 4). These RNA rearrangements most likely im-
ply significant rearrangements and conformational changes of
a number of tri-snRNP proteins. One recently identified pro-
tein, which seems a good candidate to catalyze such conforma-
tional changes, is the U4/U6 snRNP-specific 20-kDa protein.
U4/U6-20kD was shown to be a cyclophilin and therefore
termed USA-Cyp (U-snRNP-associated cyclophilin) or
SnuCyp-20 (Snurp cyclophilin-20kDa) (5, 6).
Cyclophilins form a structurally well characterized family of
closely related proteins that exhibit peptidyl-prolyl cis-trans
isomerase (PPIase) activity and thereby accelerate the folding
of proteins requiring the isomerization of a peptidyl-prolyl bond
(reviewed in Ref. 7). However, it remains unclear whether the
PPIase activity is the most important cellular function of cy-
clophilins. There is growing evidence that their main function
may be to act as chaperones and that PPIase activity is solely
a side effect (8–10). Nevertheless, purified [U4/U6.U5] tri-
snRNP particles were shown to be endowed with PPIase activ-
ity, which could be inhibited by the immunosuppressive drug
cyclosporin A (CsA), consistent with the presence of the cyclo-
philin SnuCyp-20 (6). SnuCyp-20 could be isolated in the form
of a stable RNA-free ternary complex with the U4/U6-snRNP-
specific 60- and 90-kDa proteins (5, 6), which represent the
human orthologues of the previously characterized yeast splic-
ing factors Prp4 and Prp3 (5, 11). Because SnuCyp-20 does not
interact with one of these two proteins via its active site (see
“Results and Discussion”), we have solved the crystal structure
of the SnuCyp-20 protein to get indications as to how the
formation of a complex with these proteins is accomplished.
EXPERIMENTAL PROCEDURES
The coding region of the human snucyp-20 cDNA was amplified by
polymerase chain reaction from an expressed sequence tag (EST) from
human liver (GenBankTM accession number T53949) and cloned into
the multiple cloning site of expression vector pGEX-4T-2 (Amersham
Pharmacia Biotech) resulting in a GST/snucyp-20 fusion gene. Expres-
sion of the fusion gene in Escherichia coli strain BL21(DE3) and sub-
sequent affinity purification of the resulting protein using glutathione-
Sepharose 4B (Amersham Pharmacia Biotech) was performed
according to the protocols of the vendor and yielded an almost pure
fusion protein. The GST moiety was cleaved off with 10 units of throm-
bin/mg of fusion protein and removed by gel filtration using a Superdex
75 (26/60) column (Amersham Pharmacia Biotech). The pure
SnuCyp-20 was concentrated to 10 mg ml21 in the buffer used for gel
filtration (120 mM NaCl, 2 mM DTT, 20 mM HEPES, pH 7.6) by means
of Centriprep-10 concentrators (Amicon). Crystallization of the pure
protein was performed at 21 °C in Linbro plates using the hanging drop
vapor diffusion technique. A drop of 1.5 ml of protein solution was mixed
with an equal volume of reservoir solution and sealed against 1 ml of
reservoir solution. The best crystals were obtained with 25% (w/v)
PEG6000, 200 mM MgCl2, 100 mM Tris-HCl, pH 8.5. To collect data
under cryo conditions, crystals were flash-frozen in a solution contain-
ing 25% (w/v) PEG6000, 200 mM MgCl2, 11% (v/v) glycerol, and 100 mM
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Tris-HCl (pH 8.5). A complete native data set was collected at a reso-
lution of 2.0 Å. X-ray data were collected on an R-AXIS IV image plate
system equipped with a Rigaku RU-300 rotating anode generator op-
erating at 50 kV and 100 mA and focusing mirrors (Molecular Structure
Corp.). The crystal-to-detector distance was 120 mm and 1° oscillation
images were collected with a 10-min exposure time. Diffraction data
were processed using the programs DENZO and SCALEPACK (12). The
SnuCyp-20 crystals belong to space group P212121 (cell constants: a 5
47.3 Å, b 5 59.9 Å, c 5 60.7 Å) and contain one molecule in the
asymmetric unit. The structure of SnuCyp-20 was solved by Patterson
search methods using the program X-PLOR (13) with the refined crystal
structure of hCypA (14) (Protein Data Bank code 2CPL) as a search
model. The initial electron density map was significantly improved with
the help of the program ARP (15). Model building into the electron
density map was done with the program O (16), and the structure was
refined using X-PLOR (13). The model was manually improved, and
water molecules were built with help of the program ARP (15). The final
model contains 173 amino acids and 188 water molecules and has good
stereochemistry as evaluated using the program PROCHECK (17). The
SnuCyp-20 coordinates have been deposited with the Protein Data
Bank and will be released upon publication (Protein Data Bank codes
1QOI and R1QOISF for the structure factor entry).
RESULTS AND DISCUSSION
The human snucyp-20 gene was overexpressed as a Schisto-
soma japonicum glutathion S-transferase (GST) fusion gene
(18), and the resulting gene product was affinity-purified,
yielding almost pure fusion protein. The fusion protein was
proteolytically cleaved and the GST moiety subsequently re-
moved by gel filtration. The elution volume of the pure
SnuCyp-20 from the gel filtration column corresponded to a
monomeric state. Efforts to crystallize the purified SnuCyp-20
resulted in well diffracting crystals using PEG6000 as a pre-
cipitant. A complete native data set was collected at a resolu-
tion of 2.0 Å, and the structure of SnuCyp-20 was solved by
Patterson search methods using hCypA (14) as a search model.
The data collection and refinement statistics are summarized
in Table I. The structure of SnuCyp-20, a b-barrel of eight
antiparallel b-strands and two a-helices sitting on the bottom
and top of the barrel (Fig. 1), superimposes well with the
structure of hCypA (Fig. 2). The root mean square deviation for
158 common Ca atoms of SnuCyp-20 and hCypA is 0.8 Å. Two
short 310 helices are present in SnuCyp-20. The first one lies
within the loop connecting strand b6 and b7 and is also found
in hCypA, whereas the second one, located in the loop between
helix a2 and strand b8, is not present in hCypA. The active
center of SnuCyp-20 and hCypA, as well as most residues
shown for hCypA to be involved in CsA binding, superimpose
almost perfectly, consistent with the fact that SnuCyp-20 ex-
FIG. 1. Three-dimensional structure of SnuCyp-20. Residues
that represent insertions into the primary structure, with respect to
hCypA or whose Ca-atom positions differ significantly from the corre-
sponding amino acids in hCypA are shown in red. The Fig. was pro-
duced using the programs MOLSCRIPT (33) and RASTER3D (34).
FIG. 2. Stereo view of the superpo-
sition of the Ca-backbones of hCypA
and SnuCyp-20. hCypA is shown in red
and SnuCyp-20 is blue. The superposition
was created using the program VMD (35).
TABLE I
Crystallographic data and refinement statistics
Data collection
Maximum resolution 2.0 Å
No. of observed reflections 44,280








Resolution range 3022.0 Å
R-factor,b 17.0% R-free, 22.4%
R-factorb (last shell), 19.1% R-free (last shell), 22.1%
Deviations from ideal geometry Bond lengths, 0.009 Å
Bond angles, 1.44°
a Rsym 5 S uI 2 KILu/ SI, where I is the observed intensity and KIL is the
average intensity for multiple measurements.
b R-factor 5 S{Fo 2 Fcu/ SuFou, where Fo and Fc are the observed and
calculated structure factors, respectively. R-free is the cross-validation
R-factor calculated for 10% of the reflections omitted in the refinement
process.
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hibits PPIase activity, which is inhibited by CsA.2
Two cysteine residues of SnuCyp-20, namely Cys47 and
Cys174, are also present and highly conserved within a family of
cyclophilins, whose members contain non-cyclophilin domains
and are referred to as divergent cyclophilins (19). The spatial
orientation of these cysteines renders the formation of a disul-
phide bond possible, because the distance between the sulfur
atoms of these cysteines amounts to 4.9 Å and can be reduced
to 1.7 Å by rotation of the sulfur atoms around the respective
Ca-Cb axes. However, Cys47 and Cys174 clearly exist in the
reduced form in the presented structure of SnuCyp-20 (Fig. 3).
Likewise, the crystal structure of a divergent cyclophilin from
the nematode parasite Brugia malayi reveals the reduced form
of the corresponding cysteines (19). This finding is consistent
with the fact that both the crystals of both SnuCyp-20 and the
B. malayi cyclophilin domain were obtained in the presence of
DTT.
The main differences in the primary structure of SnuCyp-20
compared with hCypA are an amino terminus elongated by
seven amino acids, the insertion of one amino acid in the loop
connecting helix a2 with strand b8, and the insertion of five
amino acids in the loop connecting helix a1 with strand b3.
Electron density can be allocated to three of the seven resi-
dues elongating the amino terminus of SnuCyp-20 compared
with hCypA, namely to Asn5, Ser6, and Ser7. The observed
conformation of these residues, however, is the result of crystal
packing contacts.
The insertion of one residue in loop a2-b8 causes the dis-
placement of residues 158–163 with respect to the correspond-
ing residues in hCypA; this leads to a significantly altered
conformation of this loop with respect to hCypA, including the
introduction of a short 310 helix (Fig. 1). The respective loops in
all other cyclophilins, whose structures have been solved (19–
25), resemble however more the loop a2-b8 of SnuCyp-20 than
of hCypA, thus rendering it unlikely that the conformation of
loop a2-b8 in SnuCyp-20 represents an adaptation to specific
requirements for its function in the spliceosome.
The insertion of five amino acids in loop a1-b3 results in the
formation of a lobe whose conformation is stabilized by two salt
bridges formed by the side chains of Glu50 and Arg52 or of Asp54
and Arg92, respectively. This lobe creates, together with amino
2 D. Ingelfinger, T. Achsel, U. Reidt, K. Reuter, R. Ficner, and R.
Lu¨hrmann, unpublished data.
FIG. 3. Stereo view of residues Cys47
and Cys174 superimposed with the 2
Fo 2 Fc electron density map. The elec-
tron density map (contoured at 1.5 s)
clearly shows the reduced form of Cys47
and Cys174 consistent with the growth of
the crystals in the presence of 2 mM DTT.
FIG. 4. Surface representation of SnuCyp-20 (A) and hCypA (B). The orientation of both molecules is identical and similar to that shown
in Fig. 2. Acidic residues are shown in red, basic residues are blue, polar residues are green, and hydrophobic residues are ochre. The enlarged loop
a1-b3 of SnuCyp-20 results in the formation of a lobe that creates, together with amino acids located in loop b4-b5, a wide cleft with a
predominantly hydrophobic character. Residues contributing to this cleft that are not present in hCypA or whose counterparts are hydrophilic in
hCypA are indicated. The surface was generated and displayed with the program VMD (35).
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acids located in loop b4-b5, a wide cleft with predominantly
hydrophobic character (Figs. 4 and 5). This cleft is not present
in hCypA or in other cyclophilins of known structure and seems
likely to create a protein-protein interaction site. SnuCyp-20
was shown to be part of a stable complex, which further con-
tains the U4/U6-90kD and -60kD proteins (5, 6). Although no
direct interaction between SnuCyp-20 and U4/U6-90kD could
be demonstrated up to the present, U4/U6-60kD was identified
as a direct binding partner of SnuCyp-20. U4/U6-60kD con-
tains seven repeats of the WD40 motif and is therefore ex-
pected to fold into a seven-bladed propeller, whose large flat
surface forms a platform of protein-protein interaction as
shown for the b-subunits of G-proteins by x-ray structure anal-
ysis (26–29). This large flat propeller surface of the U4/U6-
60kD orthologue Prp4 was shown to interact with the U4/U6-
90kD orthologue Prp3 (30) and thus may not be accessible for
SnuCyp-20.
In contrast to other known cyclophilin-protein interactions
(8, 10) SnuCyp-20 obviously does not bind U4/U6-60kD via its
catalytic site. This can be deduced from biochemical data, be-
cause hCypA, whose active site is identical to that of SnuCyp-
20, is not able to bind U4/U6-60kD. In addition, PPIase activity
could be shown for [U4/U6.U5] tri-snRNPs (6), which requires
that the SnuCyp-20 catalytic center not be occupied by U4/U6-
60kD. Finally, mutations introduced into the active site of
SnuCyp-20, which abolished its catalytic activity, did not affect
the U4/U6-60kD binding capability.2 Combining these data, it
seems likely that a region outside of the large flat surface of the
U4/U6-60kD propeller serves as an anchor site for SnuCyp-20,
which may act as a chaperone or PPIase on other sites of the
spliceosome, probably to facilitate rearrangements of protein
interactions during the splicing process.
The presented structure of SnuCyp-20, which shows a strik-
ing similarity to hCypA, reveals loop a1-b3 as well as a number
of hydrophobic residues within loop b4-b5 as good candidates
for mutational studies to figure out the interactions of this
protein with U4/U6-60kD. After the thioredoxin-like protein
U5-15kD (31, 32) this paper presents the second three-dimen-
sional structure of an snRNP-associated protein having a close
homologue in the cytoplasm, which obviously has been adopted
by the spliceosome and adjusted in the course of evolution to
the specific needs of the splicing machinery.
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FIG. 5. Alignment of the primary
structures of SnuCyp-20 and hCypA.
The SnuCyp-20 secondary structure was
assigned according to PROCHECK (17).
Residues that are identical in SnuCyp-20
and hCypA are shaded in gray. Amino
acids that are not present in hCypA or
whose Ca positions differ significantly
from the corresponding amino acids in
hCypA are shaded in magenta. The ochre-
colored dots indicate residues involved in
the formation of a hydrophobic cleft and
proposed to be involved in protein-protein
interaction.
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